Photodynamic therapy combined with itraconazole against a case of cutaneous blastomycosis

Photodiagnosis Photodyn Ther. 2021 Dec:36:102436. doi: 10.1016/j.pdpdt.2021.102436. Epub 2021 Jul 30.

Abstract

Cutaneous blastomycosis is endemic to North America and is often caused by dimorphic fungi with spores that are inhaled, inoculated spores, or hyphae that infect immunosuppressed and healthy people. It is sporadic and described as a universal imitator with morphological manifestations as erythema, nodules, and ulcers. Our case demonstrated a 69-year-old female bitten by her pet dog who was then diagnosed with cutaneous blastomycosis through social history and detailed laboratory examinations. She experienced a prolonged failure with antibacterial treatment, negative stool and tissue culture, and chronic inflammatory cell infiltrates on tissue pathology. High-throughput sequencing was performed and showed evidence of Blastomyces dermatitidis aetiology. Photodynamic therapy combined with oral itraconazole was administered, and the patient recovered in a short time. Our case presents inoculated cutaneous blastomycosis and a treatment approach in which photodynamic therapy combined with oral itraconazole significantly reduced the duration of disease treatment and affords a promising choice for the treatment of cutaneous blastomycosis.

Keywords: Cutaneous blastomycosis; Itraconazole; Photodynamic therapy.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Antifungal Agents / therapeutic use
  • Blastomyces
  • Blastomycosis* / drug therapy
  • Dogs
  • Female
  • Humans
  • Itraconazole / therapeutic use
  • Photochemotherapy* / methods
  • Photosensitizing Agents / therapeutic use

Substances

  • Antifungal Agents
  • Photosensitizing Agents
  • Itraconazole